Evaluation of Late Rectal Toxicity after Conformal Radiotherapy for Prostate Cancer A Comparison between Dose-Volume Constraints and NTCP Use

被引:0
|
作者
Cambria, Raffaella [1 ]
Jereczek-Fossa, Barbara A. [2 ,3 ]
Cattani, Federica [1 ]
Garibaldi, Cristina [1 ]
Zerini, Dario [2 ]
Fodor, Cristiana [2 ]
Serafini, Flavia [2 ]
Pedroli, Guido [1 ]
Orecchia, Roberto [2 ,3 ]
机构
[1] Ist Europeo Oncol, Dept Med Phys, I-20141 Milan, Italy
[2] Ist Europeo Oncol, Dept Radiat Oncol, I-20141 Milan, Italy
[3] Univ Milan, Milan, Italy
关键词
Treatment toxicity; NTCP; Rectum; Prostate cancer; Conformal radiotherapy; TISSUE COMPLICATION PROBABILITIES; EXTERNAL-BEAM RADIOTHERAPY; SALVAGE RADIOTHERAPY; RADIATION-THERAPY; IMRT; IRRADIATION; HISTOGRAMS; ERRORS; OPTIMIZATION; GUIDELINES;
D O I
10.1007/s00066-009-1933-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyze the reliability of different methods used in evaluating the risk of Late rectal toxicity. Patients and Methods: The treatment plans of 57 patients treated at the authors' institute between September 1999 and September 2000 for Localized prostate cancer using three-dimensional conformal radiotherapy (3D-CRT) were analyzed retrospectively. The expected rate of Late rectal toxicity was analyzed (a) by means of the dose-volume histogram (DVH) constraints; (b) by calculating the normal-tissue complication probability (NTCP) using the Lyman-Kutcher-Burman (LKB) model with the radiobiological parameters of either Emami (1991; for toxicity of grade >= 2) or Rancati (2004; for toxicity of grade >= 2 and >= 3). Patients were divided into high-/low-risk (HR/LR) groups and the results were compared to the clinical outcome. Results: (a) The HR percentages were 24% and 5% for radical and postsurgical 3D-CRT, respectively. When applying high-dose constraints only, HR percentages were 18% and 5%, respectively. (b) In the case of the NTCP (grade >= 2), Emami (1991) HR rates were 16% and 11%, and Rancati (2004) HR rates 29% and 11%, for radical and postsurgical treatment, respectively. Only one case with higher-grade toxicity was found. The reported clinical toxicity was 17.8% and 6.7% for grade >= 2 toxicity, and 3.7% and 0.7% for grade >= 3 toxicity, for radical and postsurgical treatment, respectively. Conclusion: This study demonstrated that there is an agreement between the toxicity rate evaluated by DVH constraints and by the LKB model and the clinical outcome. In this case, the use of the LKB model can be as reliable as the use of DVH constraints.
引用
收藏
页码:384 / 389
页数:6
相关论文
共 50 条
  • [41] Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
    Xingsi Peng
    Sha Zhou
    Shiliang Liu
    Jibin Li
    Sijuan Huang
    Xiaobo Jiang
    Maosheng Lin
    Shaomin Huang
    Chengguang Lin
    Chaonan Qian
    Mengzhong Liu
    Liru He
    [J]. Radiation Oncology, 14
  • [42] Long term toxicity after radiotherapy for prostate cancer: NTCP models for rectal toxicity.
    Van Vreeswijk, N. L.
    Hammer, C.
    Van den Bergh, A. C. M.
    Vanhauten, H. A. M.
    Bijmolt, S.
    Langendijk, J. A.
    Aluwini, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S332 - S332
  • [43] Late rectal toxicity after hypofractionated radiation therapy (RT) for prostate cancer: Lack of correlation with recognized dose-volume guidelines
    Faria, S. L.
    Souhami, L.
    Patrocinio, H. J.
    Joshua, B.
    Deblois, F.
    Duclos, M.
    David, M.
    Shenouda, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S11 - S11
  • [44] NTCP model to predict late urinary toxicity after prostate cancer radiotherapy
    Zhu, J.
    Simon, A.
    Ospina, J.
    Bossi, A.
    Chira, C.
    Gnep, K.
    Beckendorf, V.
    De Crevoisier, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1092 - S1092
  • [45] Dose-volume analysis of rectal hemorrhage after IMRT for prostate cancer
    Yasui, K.
    Nakamura, D.
    Egawa, A.
    Yamazaki, T.
    Hayashi, N.
    Takehara, K.
    Sakai, H.
    Uetani, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S676 - S676
  • [46] Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy
    Tucker, SL
    Dong, L
    Cheung, R
    Johnson, J
    Mohan, R
    Huang, EH
    Liu, HH
    Thames, HD
    Kuban, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1589 - 1601
  • [47] Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
    Michael J Chen
    Eduardo Weltman
    Rodrigo M Hanriot
    Fábio P Luz
    Paulo J Cecílio
    José C da Cruz
    Frederico R Moreira
    Adriana S Santos
    Lidiane C Martins
    Wladmir Nadalin
    [J]. Radiation Oncology, 2
  • [48] Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity
    Vargas, C
    Yan, D
    Kestin, LL
    Krauss, D
    Lockman, DM
    Brabbins, DS
    Martinez, AA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01): : 141 - 149
  • [49] Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy
    Hamlett, Lynsey J.
    Mcpartlin, Andrew J.
    Maile, Edward J.
    Webster, Gareth
    Swindell, Ric
    Rowbottom, Carl G.
    Choudhury, Ananya
    Aitkenhead, Adam H.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1054):
  • [50] Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
    Chen, Michael J.
    Weltman, Eduardo
    Hanriot, Rodrigo M.
    Luz, Fabio P.
    Cecilio, Paulo J.
    da Cruz, Jose C.
    Moreira, Frederico R.
    Santos, Adriana S.
    Martins, Lidiane C.
    Nadalin, Wladmir
    [J]. RADIATION ONCOLOGY, 2007, 2 (1)